The effectiveness and tolerability of agomelatine in the
treatment of depression after COVID-19 infection in Russian daily
clinical practice (TELESPHOR study)
Vladimir E. Medvedev 1, Anna N. Bogolepova2, Denis P. Morozov 3, Boris B.
Kvasnikov 3
on behalf of the TELESPHOR study investigators